Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
TERahertz ReconfigurAble METAsurfaces for ultra-high rate wireless communications (TERRAMETA)

Framework: Horizon Europe — Global Challenges and European Industrial Competitiveness
Programme: Digital, Industry and Space
Theme: Public-private partnerships
Destination: Smart Networks and Services
Action type: Research and Innovation actions
Partnership: SNS (JU-JTI)
Countries involved: Portugal,Greece,United Kingdom,Germany,Finland,France,Luxembourg,Ireland
Call: Wireless Communication Technologies and Signal Processing (HORIZON-JU-SNS-2022, 2022)
Start date: 2023-01-01
End date: 2026-06-30
Duration (months): 42.0
Total project cost (EUR): 6016739.5
EU funding (EUR): 5883264.5
Participants: 14
Project status: SIGNED

The sixth generation (6G) of mobile communications, planned around 2030, is expected to support innovative applications with requirements not met with today’s technologies, such as massive-scale communications (within IoT), the Internet of senses, holographic communications, massive digital twinning and Extreme Reality, full autonomous driving and flying networks, considering use cases in smart cities, smart home and factories (e.g. ultra-high precision 3D positioning). With the emergence of viable THz communications systems on the horizon, it is crucial to contribute THz communication and networking to the technology roadmap for beyond 6G timeframe and a step closer to industrial uptake. The TERRAMETA project aims to investigate revolutionary technologies for 6G and demonstrate the feasibility of Terahertz (THz) Reconfigurable Intelligent Surface (RIS) assisted ultra-high data rate wireless communications networks. Novel high-performance hardware including the THz RIS and THz transmitter/receiver will be developed and advanced network analysis/optimizations techniques will be developed using these real THz components. The proposed TERRAMETA THz network will be driven by 6G usage scenario requirements and indoor, outdoor, and indoor-to-outdoor scenarios will be demonstrated in real factory setting and telecom testing field. It is expected that the outcome of this project will significantly progress innovations for across the 6G Technology and systems.

Keywords: 6g reconfigurable metasurfaces reflect array transmit array terahertz cmos switch memristor ai based channel modelling signal processing beamforming cell free ultra massive mimo
Reconfiguring Moiré Quantum Materials on Demand through Strain Engineering (ReMolDS)

Framework: Horizon Europe — Excellent Science
Programme: Marie Skłodowska-Curie Actions (MSCA)
Theme: Marie Skłodowska-Curie
Destination: Postdoctoral Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Physics
Countries involved: United Kingdom
Call: MSCA Postdoctoral Fellowships 2024 (HORIZON-MSCA-2024-PF-01, 2024)
Start date: 2025-04-01
End date: 2027-03-31
Duration (months): 24.0
Total project cost (EUR): 260347.92
EU funding (EUR): 260347.92
Participants: 1
Project status: SIGNED

The rise of moiré materials based on twisted layers of two-dimensional (2D) crystals constitutes arguably one of the most exciting opportunities in the manipulation of synthetic quantum materials. Moiré materials provide an unprecedented ability to create highly tunable lattices of strongly correlated fermions with energy scales and interaction strengths that have previously been unobtainable in ‘conventional’ or other synthetic quantum materials. These properties endow moiré materials with the ability to realize experimental implementations of quantum Hamiltonians such as the Hubbard model and provide new insights into regimes not accessible by the current theoretical approaches. However, to unlock the true potential of moiré materials and navigate their rich quantum phase diagrams, a new functionality needs to be added: a wide-ranging in-situ tunability of the moiré lattice geometry and Hubbard energy scales at cryogenic temperature. ReMolDS aims to address this challenge by introducing cryogenic in-situ strain engineering to moiré heterostructures. Our project will focus on semiconducting twisted bilayer transition metal dichalcogenides (TMDs) as a prototype system. The superlubricity and robust mechanical properties of 2D materials will be leveraged to achieve extensive in-situ heterostrain at cryogenic temperatures. This innovative approach will enable precise control over the moiré geometry and periodicity, significantly expanding the tunability of these materials. We will employ optical techniques to investigate the emergent quantum phase diagrams as the moiré geometry transitions between different lattice structures, from triangular to anisotropic triangular, rectangular, and even quasi-1D configurations. Our unprecedented ability to in-situ tune and optically readout the energy scales of moiré materials with reconfigurable lattice geometries at cryogenic temperatures will guide the quest for novel exotic and technologically relevant phases of matter.

Keywords: moir heterostructures,strain engineering,twisted bilayer tmds,quantum simulators,in situ,cryogenic temperatures
Innovative low-valent tetrylene photo- and cooperative catalysis via a rational design of ligands. (MultiCoop)

Framework: Horizon Europe — Excellent Science
Programme: Marie Skłodowska-Curie Actions (MSCA)
Theme: Marie Skłodowska-Curie
Destination: Postdoctoral Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Chemistry
Countries involved: Spain
Call: MSCA Postdoctoral Fellowships 2021 (HORIZON-MSCA-2021-PF-01, 2021)
Start date: 2023-09-01
End date: 2025-08-31
Duration (months): 24.0
Total project cost (EUR): 165312.96
EU funding (EUR): 165312.96
Participants: 1
Project status: CLOSED

Catalysis is a key technology in the European economy, industry and sustainable growth for a resilient future. However, many catalytic methods in use today are not outstanding in fundamental aspects such as activity, selectivity, substrate scope, toxicity or even cost efficiency. The rich structural diversity and associated reactivity provided by heavy elements from the Main Group offer unique opportunities for the prospective substitution of traditional catalysts based on precious metals by less expensive, more abundant, and potentially less toxic Main Group compounds. Sub-valent Ge(II) and Sn(II) derivatives are particularly appealing due to their reduced HOMO-LUMO gaps and thus increased reactivity. Nevertheless, bond activation processes lead to very stable and unreactive products in higher oxidation states (+IV). As such, catalytic turnover via reductive regeneration of the active species is highly challenging. To address this problem, an interdisciplinary approach will be used combining fundamental aspects stemming from a priori independent areas of Chemistry. Rationally designed ambiphilic and bifunctional derivatives will be used as ligands for low-valent tetrylenes to induce cooperativity between Main Group elements and Transition Metals and promote novel reactivity in small molecule activation and functionalization. Another objective is to demonstrate that selective irradiation of well-designed mononuclear tetrylene will allow photoactivation of chemical bonds that are thermally inert towards many of these divalent species. However, we envision that the main advantage of using light will be in facilitating reductive elimination processes in the cases where thermal catalytic turnover is hampered by this rate-limiting step. For this reason, these studies will also be extended to our hybrid systems, in what constitutes a completely innovative research area, and where the possible synergies and cooperative mechanisms will be analyzed.

Keywords: catalysis reversibility functionalization small molecule activation cooperativity photochemistry transition metal main group elements ambiphilic ligands bifunctional ligands
Microbiome-derived asthma and allergy protective substances for prevention (APROSUS)

Framework: Horizon Europe — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Advanced grants
Action type: ERC actions
Panel: Physiology in Health, Disease and Ageing
Panel description: Organ and tissue physiology, comparative physiology, physiology  of ageing , pathophysiology, inter - organ and tissue communication, endocrinology, nutrition,  metabolism, interaction with the microbiome, non -communicable diseases including cancer (and except disorders of the nervous system  and immunity -related diseases)
Countries involved: Germany
Call: ERC ADVANCED GRANTS (ERC-2021-ADG, 2021)
Start date: 2023-01-01
End date: 2027-12-31
Duration (months): 60.0
Total project cost (EUR): 2500000.0
EU funding (EUR): 2500000.0
Participants: 2
Project status: SIGNED

Asthma and allergies are the epidemic of the 21st century after a sharp rise in prevalence since the middle of the last century. Asthma is the most common chronic condition for children – at school age about every 10th pupil is affected in westernized countries. Likewise, allergic illnesses are very prevalent with 30- 50 % of the paediatric population being affected. Currently, there is neither cure nor effective prevention. However, asthma and allergies are illnesses, which are largely environmentally determined. Exposures to the environmental microbiome greatly determine risk and protection from onset of illness in populations of common genetic make-up. My team and I have described relevant taxa of the environmental microbiome in the unique farm studies we pioneered. Very recently, we discovered the microbiome-derived functional agents conferring protection. These epidemiological findings while being scientifically cutting edge, cannot be back translated to children’s and their families’ benefit. My vision is thus to move the field of microbiome research forward towards in depth characterization of microbe-derived metabolite complexes to better understand their associated asthma- and allergy protective properties by advancing both the experimental and the human population-based studies. The interdisciplinary APROSUS Project addresses this research gap. The aims are to characterize and synthetize these functional agents (aim 1), to understand the underlying mechanisms of protection (aim 2) and to validate the findings in the population-based farm studies (aim 3). Thereby we will lay the ground for translation into innovative and effective prevention strategies to stop the asthma and allergy epidemic.
CROSSPATHS: Highway to Horizon Europe by pulling ERDF investments out of isolation through a tailored sequence of synergies (CROSSPATHS)

Framework: Horizon Europe — Widening Participation and Strengthening the European Research Area
Programme: Widening participation and spreading excellence
Theme: Improved access to Excellence
Destination: Improved access to Excellence
Action type: Coordination and support actions
Panel: Chemistry
Countries involved: Poland,Estonia,Portugal,Netherlands,France
Call: Pathways to Synergies (HORIZON-WIDERA-2023-ACCESS-04, 2023)
Start date: 2024-05-01
End date: 2026-04-30
Duration (months): 24.0
Total project cost (EUR): 1199878.75
EU funding (EUR): 1199878.75
Participants: 5
Project status: SIGNED

CROSSPATHS is an initiative of recognised scientific entities from three Widening countries Estonia (EST), Poland (PL) and Portugal (PT). Each has benefited from investments into modern agri-food research infrastructures from ERDF funds to boost their innovation capacity and establish commercialisation pathways. Each, however, acts in isolation, suffering from low international recognition, weak links to excellent European networks, poor participation in competitive grant consortia, and lacking know-how and skills on how to best valorise investments in research infrastructures and other existing assets. An insightful mapping of our competences revealed unique expertise of each Partner such as food processing with valorisation of side streams (EST), green extraction techniques with identification of plant-based bioactive compounds (PT) and in vivo validation of their health-promoting effects (PL). We form a Group capable to deliver complex solutions in a food technology, health effects and bioeconomy. The overall objective of the project is to implement cross-border pathways to put in place sequential synergies between ERDF-funded investments and Horizon Europe opportunities. This will be achieved via strategies of internationalization and HR development that improve competitiveness, knowledge transfer and strengthened innovation capacity to jointly apply for international funding. To achieve this, we will be benefiting from Wageningen Research and Innotrope experience, networks and advice. Implementation of the CROSSPATHS will make of our consortium an attractive partner for Horizon Europe projects and beyond with well trained staff and established high reputation within ERA and internationally.

Keywords: plant food,food processing,side streams valorisation,green extraction,bioactive compounds,health promoting effects
A New Light on Isocyanide Synthesis (SusIsocyanide)

Framework: Horizon Europe — Excellent Science
Programme: Marie Skłodowska-Curie Actions (MSCA)
Theme: Marie Skłodowska-Curie
Destination: Postdoctoral Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Chemistry
Countries involved: Netherlands,Germany
Call: MSCA Postdoctoral Fellowships 2021 (HORIZON-MSCA-2021-PF-01, 2021)
Start date: 2023-01-01
End date: 2024-12-31
Duration (months): 24.0
Total project cost (EUR): 189142.32
EU funding (EUR): 189142.32
Participants: 2
Project status: CLOSED

SusIsocyanide is an ambitious project that aims for the sustainable synthesis of isocyanides by combining biobased feedstock, visible light and flow chemistry. The aim is to accomplish an economically viable and ecofriendly large scale synthesis of this fundamental and highly versatile building block that has already found widespread appreciation in academia, but suffers from underutilization in the pharma-, fine-chemicals and materials industry. In accordance to the European Green Deal, the devised methodologies will provide an expedient synthetic platform to achieve the automatic synthesis of isocyanides, without the need of toxic and hazardous reagents and avoiding substantial waste production. This will constitute a ground-breaking improvement far beyond the current state-of-the-art, especially considering that the traditionally employed synthetic procedures towards isocyanides have hindered large-scale preparation and therefore industrial utilization. In light of the main goal, SusIsocyanide will constitute a launching platform for the Fellow, since the interconnection between his expertise in photoredox catalysis and flow chemistry and the experience of the host group (Maastricht University) in isocyanide chemistry provides fertile soil for fruitful collaboration and success. Because of the close collaboration in this project with Brightland Chemelot Campus, the Fellow is trained in the industrial utilization of isocyanides in polymer synthesis and advance functional material applications. This highly complements his academic knowledge with industrial application of the developed ideas. Overall, SusIsocyanide will provide a sustainable alternative for the synthesis of isocyanides, taking into account further implementation through industrial applications. The use of simple green feedstock in combination with enabling technologies is the key element that makes the difference to achieve the overall aim and objectives presented.

Keywords: isocyanide synthesis,photoflow chemistry,process intensification,polyisocyanides
Connecting Greek and Portuguese Innovation Ecosystems to Develop a Hub for Infectious Diseases Diagnostic Solutions at the Point-of Care – Tackling Cross-border Threats (DxHub)

Framework: Horizon Europe — Widening Participation and Strengthening the European Research Area
Programme: Widening participation and spreading excellence
Theme: Improved access to Excellence
Destination: Improved access to Excellence
Action type: Coordination and support actions
Panel: Life Sciences
Countries involved: Greece,Portugal
Call: Excellence Hubs (HORIZON-WIDERA-2023-ACCESS-07, 2023)
Start date: 2025-01-01
End date: 2028-12-31
Duration (months): 48.0
Total project cost (EUR): 4688625.0
EU funding (EUR): 4688625.0
Participants: 17
Project status: SIGNED

The aim of DxHub is to develop a strong ecosystem that mutually reinforces actors from two widening countries to consolidate individual efforts and allow for rapid and on the spot accurate diagnosis of infectious diseases within One-Health. The ecosystems in Crete, GR and the Oeiras region, PT, have already demonstrated a rich portfolio of activities to tackle the problem of efficient diagnosis outside a centralized lab. The DxHub will bring the two isolated regions together and, through a common R&I plan, accelerate innovations in diagnostics into impactful solutions by embracing the quadruple helix of main innovation players. Cutting-edge R&Is will be promoted based on joint research, innovation and investment plans. Pilot projects will be used to interlink academia with business providing solutions addressing the health, veterinary and agri/food sectors, all in line with both regions’ strategic priorities. In parallel, the efficient communication, dissemination and exploitation of the DxHub outcomes to the broad ecosystem will ensure high societal impact as a result of the co-development and acceptance of the new innovations by all actors of the quadruple helix. We expect that by building strong links between all payers of DxHub will foster knowledge transfer leading to the creation of new jobs and of attractive and sustainable place-based innovation ecosystems.

Keywords: one health,diagnostics,ecosystem,valorisation,excellence,hub
The best way to know your health. We have integrated a medical device into a toilet, allowing people to take an autonomous exam related to several health parameters, with simplicity and regularity. (ablute_)

Framework: Horizon Europe — Innovative Europe
Programme: European innovation ecosystems
Theme: Elevating the scalability potential of European business
Destination: Elevating the scalability potential of European business
Action type: Coordination and support actions
Countries involved: Portugal
Call: Women TechEU (HORIZON-EIE-2022-SCALEUP-02, 2022)
Start date: 2023-07-01
End date: 2024-12-31
Duration (months): 18.0
Total project cost (EUR): 107142.86
EU funding (EUR): 75000.0
Participants: 1
Project status: CLOSED

ablute_is the best way to know your health. By integrating a urinalysis device into a water-efficient toilet, people can take exams with the simplicity of using a bathroom. Regular screening is the most reliable method to early detect diseases. ablute_ delivers simplicity to health examination, fostering regularity. The equipment analysis several biomarkers simultaneously and delivers immediate results via software. If a sign of a condition is detected an alert is emitted, catching the physician and patient's attention to that condition at its early stages. The data transmitted is used for accessing patients' health but also for R&D purposes. On one hand, the biomarkers related to the analysis of diabetes, chronic kidney disease, inflammation and hypertension are already standardized, thus, the medical community already accepts them as the common used mean to monitor and detect those conditions. On the other hand, the biomarkers endorsed by ablute_ for the analysis of 5 types of cancer (breast, prostate, colorectal, bladder and ovarian), even though already validated by the scientific community with high levels of sensitivity and specificity, are still in progress for being perceived as valid by the medical community. ablute_ combine the analyses of these innovative oncological biomarkers with the standard ones, delivering relevant information while working on further validation. The toilet can be used for common purposes; However, in order to perform urinalyses, the user needs to enable a connection by pairing it with an NFC device or through facial recognition. Once connected, the toilet will open itself automatically and the person can use it like a regular toilet. ablute_ completely automatizes the process of taking a health screen, it collects a urine sample, analyzes it and delivers the results. ablute_'s goal is to democratise health examination. Step by step we are providing people with the necessary means to be the healthiest version of themselves.

Keywords: medical devices digital health big data hardware
New Work, New Reading (NWNR)

Framework: Horizon Europe — Excellent Science
Programme: Marie Skłodowska-Curie Actions (MSCA)
Theme: Marie Skłodowska-Curie
Destination: Postdoctoral Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Social Sciences and Humanities
Countries involved: Sweden,Denmark
Call: MSCA Postdoctoral Fellowships 2021 (HORIZON-MSCA-2021-PF-01, 2021)
Start date: 2022-09-01
End date: 2025-03-31
Duration (months): 31.0
Total project cost (EUR): 222727.68
EU funding (EUR): 222727.68
Participants: 4
Project status: CLOSED

The research project New Work, New Reading interrogates the relationship between new reading practices and labor. By employing computational methods to analyze reading behavior, engagement, consumption patterns and genre developments, the project investigates reading in the context of our rapidly changing workday. The project is a case study of the Scandinavian digital book market, has established partnerships with three major institutions in the Scandinavian digital literary industry and takes place at a leading Digital Humanities center in Sweden. The project studies datasets which have previously been unavailable to Danish literary scholars: literary streaming data. Drawing on my expertise in literary labor studies, I will compare reading data, surveys of contemporary readers and influential theories about the new work regime. All in all, the project contributes to studies of contemporary reading, studies of digital book publishing and computational methods in literary studies.

Keywords: reading labor digital humanities digital literature digitization